StephenLawrenceShiaoMDPhD
Radiation Oncology • Los Angeles, CABreast Cancer, Central Nervous System Cancer
Associate Professor
Dr. Shiao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
Cedars-Sinai Medical Center
Los Angeles, CA 90048Phone+1 310-423-2836Fax+1 310-659-3332
Education & Training
University of California (San Francisco)Residency, Radiation Oncology, 2008 - 2012
Yale-New Haven Medical CenterInternship, Internal Medicine, 2007 - 2008
Yale School of MedicineClass of 2007
Certifications & Licensure
CA State Medical License 2009 - 2025- American Board of Radiology Radiation Oncology
Clinical Trials
- Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis Start of enrollment: 2016 Aug 21
- Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors Start of enrollment: 2017 May 09
- Breast Cancer Study of Preoperative Pembrolizumab + Radiation Start of enrollment: 2017 Dec 22
Publications & Presentations
PubMed
- PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative ...Alice Y Ho, Stephen Shiao, Samantha A Kobald, Jonathan Chen, Dan G Duda
Journal of Clinical Oncology. 2024-12-20 - 17 citationsSingle-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.Stephen L Shiao, Kenneth H Gouin 3rd, Nathan Ing, Alice Ho, Reva Basho
Cancer Cell. 2024-01-08 - 16 citationsChronic antigen in solid tumors drives a distinct program of T cell residence.Noah V Gavil, Milcah C Scott, Eyob Weyu, Olivia C Smith, Stephen D O'Flanagan
Science Immunology. 2023-06-08
Journal Articles
- Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell CarcinomaAnthony T Nguyen, Stephen L Shiao, Zachary S Zumsteg, JAMA Oncology
Authored Content
- Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell CarcinomaAugust 2020
- Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell CarcinomaAugust 2020
- Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell CarcinomaAugust 2020
- Human Papillomavirus–Associated Oropharyngeal Cancer Among Patients Aged 70 and Older: Dramatically Increased Prevalence and Clinical ImplicationsOctober 2018
- Join now to see all
Press Mentions
Researchers Demonstrate How Tumors Make Immune Cells Less EffectiveJune 27th, 2022- Tumors Change Nearby Immune Cells to Promote Tumor GrowthJune 22nd, 2022
- Soft-Tissue Sarcomas Changes the Biology of Immune Cells Surrounding Tumors to Promote Tumor GrowthJune 22nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
